David Murphy
Foot & Ankle Surgery · Waycross, GANPI 1194755447
Payments from drug & device makers
What this record shows
This record is dominated by other: $49,240 of the $54,779 with a category attached, or 89.9%. Convatec Inc. accounts for 89.9% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $49,240 and has fallen 99.9% since, to $49 in 2025. Among foot & ankle surgery clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 25 payments — averaging $2191.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$49K
- Intelivation Technologies, LLC$5K
- Organogenesis Inc.$328
- Paragon 28, Inc.$94
- Arthrex$49
- Amgen$38
- plus $30 from 1 others
What the payments were for
- Consulting fees$5,0009%
- Food & beverage$5391%
- Other$49,24090%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 6 | $49,240 |
| Intelivation Technologies, LLC | 1 | $5,000 |
| Organogenesis Inc. | 12 | $328 |
| Paragon 28, Inc. | 1 | $94 |
| Arthrex | 1 | $49 |
| Amgen | 2 | $38 |
| Smith+Nephew | 2 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$49,240
- Apligraf$125
- Dermagraft$125
- Puraply/Affinity/NuTech$125
How this compares
$54,779 in reported general payments places this provider in the 95th percentile of 239 foot & ankle surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 14 | $312 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Waycross
- Robert WeinsteinFayetteville$394K
- Jason BariteauAtlanta$199K
- Scott RomanPeachtree City$118K
- Jeffrey FlashForest Park$114K
- Mickey StappThomson$110K
- Rishin KadakiaAtlanta$53K
- Javan BassLithonia$43K
- Bhavin MehtaAtlanta$43K
- Corbett ThigpenAugusta$41K
- Eric MassaTifton$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.